EZH2 and chronic obstructive pulmonary disease: EZH2 immunoreactivity significantly increased in bronchial epithelium of COPD Smokers compared to Smokers subjects and to COPD ex-smokers (p < 0.001 and p < 0.001, respectively) and in COPD ex-smokers compared to Smokers (p < 0.04).